Pharmaceutical intermediates
Crisaborole Intermediates
4 pharmaceutical intermediates for Crisaborole. Indication: Atopic Dermatitis.
About Crisaborole
- Originator
- Anacor Pharmaceuticals Inc
- Indication
- Atopic Dermatitis
- Approved Date
- 12/14/2016
- DS/DP
- 02/16/2027
Available intermediates
4 intermediates currently listed for Crisaborole. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 2-BROMO-5-HYDROXYBENZALDEHYDE | 2973-80-0 | / | / |
| 4-(4-Bromo-3-formyl-phenoxy)-benzonitrile | 906673-54-9 | / | / |
| 4-[4-bromo-3-(hydroxymethyl)phenoxy]benzonitrile | 906673-45-8 | / | / |
| [2-bromo-5-(4-cyanophenoxy)phenyl]methyl acetate | 2227126-09-0 | / | / |
Building toward Crisaborole?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →